Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter May 29, 2015

Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome

Heves Kırmızıbekmez, Rahime Gül Yesiltepe Mutlu, Fatma Dursun and Şükriye Pınar İşgüven

Abstract

Tamoxifen, a selective estrogen receptor modulator, has been used in the treatment of peripheral precoccious puberty. A 5-year and 3-month-old girl, diagnosed with McCune-Albright syndrome, came in with abnormal hair growth approximately 2 months after the initiation of tamoxifen. The pattern of terminal hair on the skin following the administration of the drug and the exclusion of other causes suggested tamoxifen-induced hirsutism.


Corresponding author: Heves Kırmızıbekmez, Zeynep Kamil Obstetrics and Children Education and Research Hospital, Pediatric, Endocrinology, Barbaros mah. Sedef sok. No:3-E D:15, Üsküdar İstanbul, Turkey, Phone: +216 3910680, Mobile: +505 8148802, E-mail:

References

1. Mieszczak J, Eugster EA. Treatment of precocious puberty in McCune-Albright syndrome. Pediatr Endocrinol Rev 2007;4: 419–22.Search in Google Scholar

2. Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003;143:60–6.10.1016/S0022-3476(03)00128-8Search in Google Scholar

3. Hohl A, Ronsoni MF, Oliveira M. Hirsutism: diagnosis and treatment. Arq Bras Endocrinol Metab 2014;58:97–107.10.1590/0004-2730000002923Search in Google Scholar PubMed

4. Ferriman DM, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol 1961;21:1440–7.10.1210/jcem-21-11-1440Search in Google Scholar PubMed

5. Al-Niaimi F, Lyon C. Tamoxifen-induced hirsutism. J Drugs Dermatol 2011;10:799–801.Search in Google Scholar

6. Nolvadex Side Effects Center. Review: could tamoxifen citrate cause hrsutism? Feb, 26, 2014 (eHealthMe).Search in Google Scholar

7. Zhou J, Ng S, Famuiya OA, Anderson K, Bondy CA. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. The FASEB J 2000;14:1725–30.10.1096/fj.99-0863comSearch in Google Scholar PubMed

Received: 2014-10-18
Accepted: 2015-4-9
Published Online: 2015-5-29
Published in Print: 2015-9-1

©2015 by De Gruyter

Scroll Up Arrow